Stock screener

ROIV

Conviction 60HealthcareScan · Thu, Sep 24, 2026

Roivant Sciences Ltd. (ROIV) closed at $36.14 (-1.85%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 42, RS Rating 95, -13.6% from its 52-week high, +64.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ROIV$36.14-1.85%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
4
2
4
6
7
Vol MA14 10.75M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Roivant Sciences Ltd.PHARMACEUTICAL PREPARATIONSwww.roivant.com ↗
Price36.14
Change-1.85%
Gap-0.87%
Rel volume1.27×
Avg volume11.18M
Avg $ vol424.99M
SMA 2038.00
SMA 5036.39
SMA 20029.73
Price vs 50-0.70%
Price vs 200+21.57%
MA stackmixed
50/200 cross—
Supertrenddown · 40.70
RSI (14)42
MACD hist-0.42
MACD crossbear · 2d
Stoch %K / %D26 / 38
ADX (14)20
+DI / −DI24 / 31
RSI divergence—
MACD divergence—
ATR %4.02%
ADR %3.79%
52w high41.81
52w low14.70
From 52w high-13.56%
Above 52w low+145.85%
New 52w highNo
SqueezeOff
Bollinger width27.98%
%B0.32
Donchian pos29.88%
Donchian high42.50
Donchian low33.43
AVWAP (52w high)39.79
vs AVWAP high-9.18%
AVWAP (52w low)27.37
vs AVWAP low+32.03%
OBV trendDown
Chaikin MF (20)-0.22
Today vs 20d1.27×
Avg vol (14d)10.75M
Avg vol (20d)11.18M
Avg $ vol (20d)424.99M
Market cap—
RS Rating95 / 99
RS 3m (vs SPY)+1.74%
RS 6m (vs SPY)+15.27%
RS line new highNo
Trend template7/8
Technical rank74.8
1 week-9.60%
1 month-0.90%
3 months+6.23%
6 months+32.09%
1 year+145.18%
YTD+64.80%
P/E-88.73
P/B6.29
P/S—
P/FCF-35.07
EPS-0.5400
Div yield—
ROE-7.08%
ROA-5.65%
Debt/Eq0.05
Current16.72
EV/EBITDA-49.97
Gross margin—
Net margin—
Rev growth-71.57%
EPS growth-74.30%
Price target47.78
Target upside29.75%
Analyst ratingBuy
Institutional83.53%
Ent. value25.57B
Revenue1.44M
Net income-189.84M
Gross profit—
Free cash flow-758.56M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out719.27M
Employees721
ListedFri, Oct 1, 2021
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction60 / 100
Pattern quality—
Tech rank74.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance40.24
Support32.79
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ROIV · 3 recent

All disclosures →
MemberSideAmount
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-30
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-31
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in ROIV · open-market 6 sells

InsiderSideShares
Fitzgerald Meghan
Director · Common Shares · 2026-09-15
Sell4.71K
Epperly Melissa B,
Director · Common Shares · 2026-09-15
Sell4.34K
Epperly Melissa B,
Director · Common Shares · 2026-09-15
Sell600
Fitzgerald Meghan
Director · Common Shares · 2026-09-15
Sell400
Pulik Richard
CFO · Common Shares · 2026-08-20
Tax5.75K
Venker Eric
President & Immunovant CEO · Common Shares · 2026-08-20
Tax13.91K
Sukhatme Mayukh
President & CIO · Common Shares · 2026-08-21
Sell144.76K
Sukhatme Mayukh
President & CIO · Common Shares · 2026-08-21
Exercise144.76K
Sukhatme Mayukh
President & CIO · Stock Option (Right to Buy) · 2026-08-21
Exercise144.76K
Sukhatme Mayukh
President & CIO · Common Shares · 2026-08-20
Sell17.52K

SEC filings

EDGAR filings in ROIV · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.